We have investigated the effect of cis-diamminedichloroplatinum(II) (CDDP) on signal transduction pathways. CDDP treatment did not cause any change in the binding of 1H1-phorbol dibutyrate to PC-9 (human lung adenocarcinoma cell line) cells, a measure of protein kinase C activation. However, 2-h CDDP treatment (20 gg/ml) caused -200% increase in 1,2-sn-diacylglycerol (DAG) production and -50% decrease in inositol 1,4,5-triphosphate production. To explore the different source of DAG, we analyzed phospholipids labeled with I"Cicholine by TLC and revealed that ['4Cjcholine-labeled phosphatidylcholine (PC) was decreased to 50% by CDDP treatment. This suggested that PC turnover was increased by CDDP-treatment. PC-specific phospholipase C (PC-PLC) activity was increased to 2.5-fold (2.58±0.28 nmol/mg protein per min) by 2 h CDDP (20 ;&g/ml) treatment compared with control (1.05±0.24 nmol/mg protein per min). Treatment of CDDP also stimulated PC-PLC in the crude membrane extract from PC-9 cells. CDDP had no effect on the activities of phospholipase A2 and D. Trans-DDP, which has far less cytotoxicity than its stereoisomer, CDDP, did not cause any change in PC-PLC activity. A significant inhibition of DNA synthesis (< 80%) occurred 4 h after 2 h CDDP (20 ;&g/ml) treatment.
Introduction cis-diamminedichloroplatinum(II) (CDDP)' is a key anticancer agent for the treatment of solid tumors (1) . Phorbol esters, such as 12-O-tetradecanoylphorbol 13 -acetate (TPA), Receivedforpublication 12 September 1991 and in revisedform 12 December 1991.
1. Abbreviations used in this paper: CDDP, cis-diamminedichloroplatinum(II); DAG, 1,2-sn-diacylglycerol; dH2O, distilled water, G proteins, GTP-binding proteins; IP3, inositol 1,4,5-trisphosphate; LPC, lysophosphatidylcholine; PA, phosphatidic acid; PBt2, phorbol dibutyhave various biological effects on a variety ofcellular functions (2, 3) . Several recent studies have shown that TPA could modulate CDDP-induced cytotoxicity (4-6). Hofmann et al. (4) have observed sensitization of Walker rat carcinoma cells to CDDP by long-term (48-h) exposure to TPA and have postulated that the sensitization effect of TPA resulted from the inhibition or downregulation ofprotein kinase C (PKC). Basu et al. (5) have also observed that long-term (24-h) pretreatment with TPA sensitized HeLa cells to CDDP, but they have shown that the downregulation of PKC could not explain the sensitizing effect of TPA and postulated that activation of PKC was necessary for sensitization to CDDP. Isonishi et al. (6) have reported that short-term (1-h) TPA exposure could sensitize 2,008 ovarian carcinoma cells to CDDP. Although they did not measure the actual PKC activity, they suggested that CDDP sensitivity could be modulated by PKC.
We have recently reported that CDDP-resistant human lung cancer cell line was cross-resistant to the growth-inhibitory effect of TPA (7) . Considering that TPA modulated CDDP-induced cytotoxicity and that CDDP-resistant cells showed cross-resistance to TPA, we can speculate that TPA and CDDP have a somewhat common mechanism ofaction in their growth-inhibitory effect and cytotoxicity.
The effects of TPA appear to be mediated largely through signal transduction pathways involving PKC activation (2, 3) . Recent evidence suggests that TPA acts on phosphatidylinositol (PI)-specific phospholipase C (PI-PLC) (8) (9) (10) (11) (12) and phosphatidylcholine (PC)-specific phospholipase C (PC-PLC) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) , both of which are considered to be important enzymes in signal transduction pathways. However, there have been few reports describing the effect of CDDP on signal transduction pathways; the reports have focused only on PKC activity (24) .
For this report we investigated the effect ofCDDP on signal transduction pathways and demonstrated that CDDP has no effect on PKC activity and that CDDP activates PC-PLC. This PC Cell cultures. PC-9 is a human non-small cell lung cancer cell line (25) . Cells were grown in RPMI 1640 medium supplemented with 10% fetal bovine serum, penicillin (100 U/ml), and streptomycin (100 ,g/ ml) in a humidified 5% CO2 atmosphere at 370C.
Assayfor cellular 1,2-sn-diacylglycerol (DAG). At various time periods after the addition of20 ,g/ml CDDP, lipids of PC-9 cells (2 x I05 cells) were extracted with chloroform/methanol (2:1) (vol/vol). Then, we added 1.25 vol of chloroform and 1.25 vol of 0.2 M KCI-5 mM EDTA solution. After centrifugation at 1,000 g for 10 min at 4VC, lipids in organic phase were extracted by the modified method of Bligh and Dyer (26) . Samples in the organic phase were dried under N2 gas, and DAG mass was assayed according to the method of Preiss et al. (27) . The assay was linear with respect to DAG mass from 0.2 to 5 nmol.
Assayfor inositol 1,4,5-trisphosphate (IP3). At various time periods after the addition of 20 Mg/mi CDDP, 1 ml of PC-9 cell suspension (2 X I05 cells/ml) was mixed with 200 AI ice-cold 20% perchloric acid and kept on ice for 20 min. Proteins were sedimented by centrifugation at 2,000 g for 15 min at 4VC. Supernatants were transferred to the new tubes and were neutralized to pH 7.5 by 1 M KOH and kept on ice for 1 h. Then we added 4 ml distilled water (dH20) to the neutralized supernatants. This solution was applied to the minicolumn (Amprep, Amersham) at a flow rate of 3 ml/min. The column was washed once with 5 ml ofdH2O and once with 5 ml of0.1 M KHCO3 at the same flow rate. The IP3 fraction was eluted with 5 ml of 0. 17 Labeled cells were washed once with warmed PBS and were exposed to various concentrations ofCDDP for 2 h. Reactions were terminated by removing the supernatants and the cells were washed three times with cold medium containing unlabeled 1 mM choline. Then we added 2 ml of ice-cold methanol and transferred the cells to glass tubes after a 10-min incubation at 4°C. The washed culture dish was rinsed twice with 1 ml of ice-cold methanol and we added this solution to the glass tubes mentioned above. We then added 2 ml ofchloroform and left the extracts for 1 h at 4°C. The tubes were then centrifuged at 400 g for 10 min. Organic phases were dried under N2 gas and lipids were fractionated by TLC using the following solvent systems. For the fractionation ofdifferent phospholipids, chloroform/methanol/concentrated ammonia (65:25:4) (vol/vol/vol) was used in the first dimension and chloroform/acetone/methanol/acetic acid/water (30:40:10:10:5) (vol/vol/ vol/vol/vol) was used in the second dimension. The spot corresponding to each lipid, located by autoradiography, was scraped offthe plate; and the radioactivity of each lipid was measured in a liquid scintillation counter.
Preparation of membrane fraction. Subconfluent cells were harvested and washed twice with ice-cold buffer 1 (PBS containing 1 mM EDTA [pH 7.3] ). Collected cells were resuspended in buffer 2 (2 mM Hepes, 154 mM NaCl, 1 mM EDTA, pH 7.4) at 6 X 106 cells/ml. After freezing and thawing twice, the cell suspension was sonicated in a bath sonicator for 30 s. Before ultracentrifugation, an aliquot of fresh sonicate was centrifuged at 180 g for 10 min at 4°C. The supernatant was then centrifuged at 100,000 g for 90 min at 4°C (Ultracentrifuge TL-100 with a fixed-angle rotor TL-45, Beckman Instruments, Fullerton, CA). After ultracentrifugation the pellet was resuspended in buffer 2. Membrane fractions were immediately frozen at -80°C until use. Protein content was measured by the method of Lowry et al. (28 
Results
Effect of CDDP on PKC and PI-hydrolysis. To examine the effect of CDDP on signal transduction pathways, we initially determined the dose-dependent effect of 2 h CDDP treatment on DAG production, IP3 production, and phorbol dibutylate (PBt2) binding to PC-9 cells. The activation of PKC has been correlated with its translocation from the cytosol to cellular membranes and a subsequent increase in the binding of [3H]-PBt2 to intact cells (29, 30) . Therefore, PBt2 binding reflects PKC activity. DAG production was stimulated in a dose-dependent manner by 2 h CDDP treatment (Fig. 1 a) . However, IP3 production was inhibited by higher concentrations (> 20 ,gg/ml) ofCDDP treatment (Fig. 1 b) The physiological activation of PKC generally results from acute increase in cellular DAG content. In the following experiments, we examined DAG production, IP3 production, and PBt2 binding to the cells at various times within 2 h after the addition ofCDDP (20 ,g/ml). By the use ofa colony formation assay (2 h CDDP exposure), CDDP concentration of 20 ,g/ml killed 90% of the cells at the time of colony counting (day 10) (unpublished data). However, 2 h after the addition of 20 ,ug/ml CDDP, we could not observe any decrease in cell numbers or viability as counted by trypan blue staining. CDDP treatment caused an increase ofDAG production 30 min after the addition of CDDP (Fig. 2 a) . DAG production doubled after 2 h. However, unexpectedly, there no increase of PBt2 binding to the PC-9 cells occurred within 2 h (data not shown) and a significant inhibition of IP3 production (Fig. 2 b) was observed. The hydrolysis of phosphatidylinositol 4,5-bisphosphate by PI-PLC is an important source ofDAG and IP3, but it is now known that PC can also be hydrolyzed by PC-PLC to yield DAG. To explore the different source ofDAG, the following experiment was carried out.
CDDP treatment increased PC turnover. To examine the effect of CDDP addition to quiescent PC-9 cells on PC-PLC- Fig. 3 indicate that the level of 14C-labeled PC was decreased in a dose-dependent manner after 2 h CDDP treatment. The decrease was observed above 2 gg/ml of CDDP concentrations and in fact the change of 14C-labeled PC was inversely correlated with the change of DAG production. Furthermore, the level of 14C-labeled PC was decreased in a time-dependent manner when the cells were treated with 20 ,g/ml ofCDDP for 2 h. After 2 h, the level of '4C-labeled PC was 50% of that of control cells (data not shown). Considering the results that CDDP increases PC turnover, we then examined whether PC hydrolysis was affected by CDDP treatment in the following experiments.
CDDP treatment increased PC-PLC activity, but not PLA2 activity. Formation of PA and DAG by stimulated cells could occur by several distinct pathways (Fig. 4) . PC can be hydrolyzed by PC-PLC to yield DAG described above. The resultant DAG is then phosphorylated by DAG kinase to PA (31) . PA is also formed by direct action of phospholipase D (PLD) on PC (32) (33) (34) (35) (36) (37) (38) (39) . SM is also formed by PLD. PA, thus, is formed from PC and DAG by PLD and DAG kinase. On the other hand, PLA2 formed LPC and arachidonic acids from PC. We compared each production of DAG, LPC, PA, and SM before and after CDDP treatment. As shown in Fig. 5 , PA and SM productions were much lower than those of DAG and LPC. And after CDDP treatment we observed no change of SM production We then examined whether PC-PLC and PLA2 activities were affected by CDDP treatment. Membrane fractions from the PC-9 cells with or without 2 h CDDP (20 ,g/ml) treatment were used for the measurement of each enzyme activity. PC-PLC activity was calculated from ["4C]DAG production. PLA2 activity was calculated from ['4C]LPC production. Without CDDP treatment, PC-PLC activity was 1.05±0.24 (nmol/mg protein per min) and PLA2 activity was 0.55±0.18 (nmol/mg protein per min). After 20 ,ug/ml of CDDP treatment for 2 h, PC-PLC activity increased -2.5-fold (2.58±0.28 nmol/mg protein per min), but PLA2 activity (0.50±0.17 nmol/mg protein per min) was almost same as the control experiment. We also examined these enzyme activities in homogenates of whole cells. We could find the lack of change in LPC in whole cells in the same treatment condition. On the other hand, the activation of PC-PLC activity by CDDP was also observed in whole cells. These results support the activation of PC-PLC and the lack of activation of PLA2 in membranes. These findings are consistent with the findings demonstrating the increased DAG production and increased PC turnover in CDDPtreated cells.
To examine whether CDDP-induced PC-PLC activation was related to CDDP-induced cytotoxicity, we examined the in vitro effect of CDDP and trans-DDP on PC-PLC activity, respectively. Trans-DDP has far less cytotoxic ability than its stereoisomer, CDDP. Results in Fig. 6 a clearly indicate that CDDP caused an increase in PC-PLC activity, but trans-DDP did not cause any change of PC-PLC activity. Moreover 
Discussion
We have demonstrated that CDDP treatment caused an increase in PC-PLC activity to yield an increase in PC turnover and DAG production and that CDDP treatment caused a decrease in IP3 production but had no effect on PKC activity in a human non-small cell lung cancer cell line. (41), but most studies focused on its role in positive regulation on cell proliferation. Issandou et al. (42) have reported that permeant diacylglycerol 1,2-diotanoyl-sn-glycerol (DiC8) had a growth inhibitory effect on an MCF-7 breast cancer cell line and that DiC8 mimicked the effects of TPA on cell growth inhibition. We have previously demonstrated that CDDP-resistant PC-9 cells, PC-9/CDDP, showed cross-resistance to the growth inhibitory effect of TPA. These results suggested that DAG had a potential role in the negative regulation of cell proliferation as TPA had in some cells and that DAG had some role in CDDP-induced cytotoxicity.
We have demonstrated increased DAG production and decreased IP3 production in PC-9 cells after CDDP treatment. We could not show an increase in PKC activity although an increase in DAG has occurred. If the source of DAG was only PI, these results would be contradictory considering the known characteristics of PI-derived DAG. However, recent evidence has demonstrated the existence of another phospholipid pathway leading to DAG production (20, 43, 44) . PC-PLC-mediated hydrolysis ofPC is now thought to be another important source ofDAG (45, 46) . And PC-derived DAG has been shown to have different fatty acid composition (47) and functions (48, 49) . Although the distinct role of PC-derived DAG is not known, recent studies have demonstrated that PC-derived DAG did not cause PKC activation in vivo (50, 51) . Further support for these results is that we have demonstrated increased PC-PLC activity to yield increased DAG production and no change of PKC activity after CDDP treatment. Our results suggest a novel function of PC-derived DAG.
Although we did not examine PI-PLC activity directly, it might be inhibited by CDDP treatment in that a decreased IP3 production was observed in the present study. Recent reports have shown that analogues of PI such as hexachlorocyclohexanes (52) and manoalide (53) inhibited PI-PLC activity and caused a growth inhibition oftumor cells (54) (55) (56) . These results suggested inhibition of PI-PLC activity and subsequent inhibition of PI turnover were important processes in the negative regulation of cell growth.
The mechanism whereby CDDP increases PC-PLC activity in PC-9 cells remains to be clarified. The activation mechanism ofCDDP on PC-PLC could be through a direct effect ofCDDP on the enzyme or substrate or through an influence on the regulatory mechanisms for PC-PLC. Some GTP-binding protein (G protein) has been suggested to be involved in the coupling of various agonist receptors to PI-PLC (57) and pertussis toxin; i.e., it interferes with the receptor-linked PI-PLC reaction in some tissues (12). On the other hand, there is some evidence to support the involvement ofa G protein in receptordependent activation of PC breakdown by PLC (58) Considering that CDDP-induced PC hydrolysis took place before a significant inhibition ofDNA synthesis and that trans-DDP could not induce PC-PLC activation, PC-PLC activation and subsequent hydrolysis of PC might be important steps for CDDP-induced cytotoxicity. Further support for this comes from our preliminary data that 20 ,ug/ml of CDDP, which caused a significant increase in PC-PLC activity and in DAG production in the PC-9 cells, did not cause the same effect in -30-fold CDDP-resistant PC-9/CDDP cells. This suggests that change in phospholipid metabolism, described in this report, might contribute to the mechanism of acquired CDDP resistance and reinforces our hypothesis that the change of phospholipid metabolism might related to CDDP-induced cytotoxicity.
Almost all ofthe previous studies investigating the relationship between anticancer agent sensitivity (or cytotoxicity) and signal transduction pathways have focused only on the change of PKC and/or PI turnover. However, the results presented here suggest that PC metabolism might have an important role in anticancer drug-induced cytotoxicity.
The CDDP effect on PC metabolism seems to mimic to the effect of IL-1 (63) , (64) , and Interferon a (65) . In interferon a, PC-hydrolysis is coupled to the growth inhibitory effect. Considering these evidences, we could speculate about the possibility for the combination of CDDP and these compounds. Recently, it has been demonstrated that many lipid compounds, including phosphatidylcholine analogues and ether-lipids analogues, have antitumor effects against several kinds oftumor cells (66) . These compounds were also expected to be used in the combination with CDDP.
